• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL INJECTOR LUER LOCK N35; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL INJECTOR LUER LOCK N35; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 515003
Device Problem Leak/Splash (1354)
Patient Problem No Information (3190)
Event Date 06/11/2020
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that bd phaseal¿ injector luer lock n35 leaked during use.The following information was provided by the initial reporter: there is a leakage at the bottom of the injector device through the opening.
 
Event Description
It was reported that bd phaseal¿ injector luer lock n35 leaked during use.The following information was provided by the initial reporter: there is a leakage at the bottom of the injector device through the opening.
 
Manufacturer Narrative
H6.Investigation: one photo was provided to our quality tram for investigation.Upon inspection of the photo, the location of the leak is indicated, however, there is no visible evidence a leak occurred.A device history was performed and found no no-conformances related to the reported issue during production of batch 2002115.Three retained samples of the same lot were used for additional evaluation.The product was evaluated and no damage or defects were observed.Functional testing was performed on the sample using a protector and syringe.Each sample was tested ten times and no leakages were observed.Product undergoes visual and functional testing through manufacturing, ensuring all critical dimension are within specification.Results were reviewed for the reported lot and no issues related to the reported incident were identified.Based on the available information we are not able to identify a root cause related to the manufacturing process at this time.H3 other text : see h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL INJECTOR LUER LOCK N35
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
MDR Report Key10228599
MDR Text Key198736708
Report Number3003152976-2020-00285
Device Sequence Number1
Product Code ONB
UDI-Device Identifier30382905150037
UDI-Public30382905150037
Combination Product (y/n)N
PMA/PMN Number
K140591
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 07/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date07/31/2022
Device Model Number515003
Device Catalogue Number515003
Device Lot Number2002115
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/11/2020
Initial Date FDA Received07/03/2020
Supplement Dates Manufacturer Received06/11/2020
Supplement Dates FDA Received07/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-